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Abstract
Background: HIV-1 superinfection occurs at varying frequencies in different at risk populations. Though
seroincidence is decreased, in the negative partner of HIV-discordant couples after joint testing and counseling in
the Zambia Emory HIV Research Project (ZEHRP) cohort, the annual infection rate remains relatively high at 7-8%.
Based on sequencing within the gp41 region of each partner’s virus, 24% of new infections between 2004 and
2008 were the result of transmission from a non-spousal partner. Since these seroconvertors and their spouses
have disparate epidemiologically-unlinked viruses, there is a risk of superinfection within the marriage. We have,
therefore, investigated the incidence and viral origin of superinfection in these couples.
Results: Superinfection was detected by heteroduplex mobility assay (HMA), degenerate base counting of the
gp41 sequence, or by phylogenetic analysis of the longitudinal sequences. It was confirmed by full-length env
single genome amplification and phylogenetic analysis. In 22 couples (44 individuals), followed for up to five years,
three of the newly infected (initially HIV uninfected) partners became superinfected. In each case superinfection
occurred during the first 12 months following initial infection of the negative partner, and in each case the
superinfecting virus was derived from a non-spousal partner. In addition, one probable case of intra-couple HIV-1
superinfection was observed in a chronically infected partner at the time of his seroconverting spouse’s initial
viremia. Extensive recombination within the env gene was observed following superinfection.
Conclusions: In this subtype-C discordant couple cohort, superinfection, during the first year after HIV-1 infection
of the previously negative partner, occurred at a rate similar to primary infection (13.6% [95% CI 5.2-34.8] vs 7.8%
[7.1-8.6]). While limited intra-couple superinfection may in part reflect continued condom usage within couples, this
and our lack of detecting newly superinfected individuals after one year of primary infection raise the possibility
that immunological resistance to intra-subtype superinfection may develop over time in subtype C infected
individuals.
Background
HIV-1 superinfection presents an additional concern to
the already challenging problem of HIV-1 vaccine design
in the face of the virus’s rapid evolution [1]. Superinfec-
tion is defined as a reinfection by a heterologous HIV-1
strain after a primary immune response has already
been mounted [2]. Superinfection and coinfection
(primary infection with two genetically distinct viruses)
differ based on whether the second infection is con-
tracted prior to or after the host immune response has
been mounted [3]. The first documented case of super-
infection was identified in a high-risk MSM individual,
initially infected with a CRF01_AE subtype followed by
a subtype B superinfection after two years [4]. Several
other cases have been reported, demonstrating a spec-
trum of intersubtype [5-12], intergroup [13] and intra-
subtype [14-17] superinfections.
Many studies have raised questions about the fre-
quency of superinfection and were unable to identify
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HIV-1 superinfection in the populations under investi-
gation [18-21]. Despite these doubts, HIV-1 superinfec-
tion has now been seen to occur at frequencies
comparable to primary infection in certain cohorts
[5,17]. The behavioral aspects of these cohorts impact
transmission [22] and the interplay between the risk for
re-exposure [23], as well as the regional HIV-1 preva-
lence have been thought to influence the likelihood of
HIV-1 superinfection in a given population [3].
It is known that HIV-1 superinfection occurs despite
broad CD8+ T-cell [14] and cross-reacting neutralizing
antibody responses [24], although it appears that there
is less likelihood for HIV-1 superinfection later in the
course of HIV infection [17,25,26]. Studies have evalu-
ated the neutralizing antibody population around the
time of superinfection and demonstrated both lack of
neutralizing antibody [27] as well as robust neutralizing
responses [24].
HIV-1 superinfection has clinical ramifications. Trans-
mission of drug resistant variants through superinfection
has been well described [16,17,28-30] and there has been
evidence of increased viral load set-points in individuals
who are dually infected [31,32] or superinfected [14,16].
The numerous circulating recombinant forms of HIV-1
demonstrate that dual infection of individuals [9,33,34] and
the resulting superinfection can contribute to the overall
diversity of a virus population. Modeling has shown that
intrasubtype superinfection may be as high as 15% in some
populations based on evidence of recombination [35], and
superinfection followed by recombination may contribute
to immune escape within an individual [36].
Since 1994, the Zambia Emory HIV Research Project
has followed a cohort of HIV-1 discordant couples,
where one partner is HIV-infected and the other is
HIV-uninfected. Joint counseling and condom provision
in such couples can reduce transmission significantly
[37-40]. When HIV-1 infections occur, approximately
one in eight are acquired from non-spousal partners,
leading to a couple infected with genetically distinct
viruses [41]. We have followed 22 of these epidemiologi-
cally unlinked couples longitudinally for at least 1 year
and up to 5 years, to determine the frequency and nat-
ure of superinfection in this cohabiting heterosexual
population. We observed superinfection in four out of
44 individuals, but only one of these involved transmis-
sion of virus from one spouse to the other. The other
superinfections resulted from transmissions from non-
spousal partners within one year following a primary
HIV-1 infection acquired in an extra-marital relation-
ship. Thus, superinfection from non-spousal partners
occurs more commonly than between spousal partners
in this cohort, although evidence for continued condom
use between spousal partners could limit the incidence
of intra-couple HIV-1 superinfection.
Results
Selection of the study couples
Two hundred and two HIV-1 discordant couples who
seroconverted to concordant infected status (both part-
ners HIV-infected) from 2002-2008 in the ZEHRP
cohort were screened for epidemiologic linkage as
described previously [41]. In this subset of 202 couples,
49 (24%) were found to have partners with genetically
distinct viruses (epidemiologically unlinked transmis-
sions), and 22, selected as described in Methods, were
screened for HIV-1 superinfection. Three approaches
were employed (see Methods): 1) quantitation of degen-
erate bases in viral population sequences of the genomic
regions encoding the ectodomain of gp41 and gag, 2)
phylogenetic tree and Highlighter tool analyses of these
sequences, and 3) heteroduplex mobility assay (HMA)
of gp41 amplicons. If any of these methods suggested
dual infection (either superinfection or co-infection -
see Methods), longitudinal single genome amplification
(SGA) of the full-length env gene was performed in
order to further confirm and characterize the dual infec-
tion. Of the 22 acutely infected individuals, there were 9
women and 13 men; none of the participants reported
undergoing antiretroviral therapy or engaging in risk
behaviors other than heterosexual sex. The ZEHRP
cohort is primarily (96.9%) subtype C [41,42], and as
expected, all 44 of the individuals had primary infection
with subtype C HIV-1. The length of screening for indi-
viduals ranged from 12-66 months, with at least 3 time
points analyzed during the length of the screening for
the acute partner.
Identification of dual infections using PCR amplified gp41
sequences and highlighter tool analysis
For each individual, a 399 bp fragment within the gp41
ectodomain region of the env gene was PCR amplified
from each longitudinal sample time point as described
in Methods. Degenerate bases (DB) were scored when a
secondary peak exceeded 30% of the major peak height
in the sequence traces. A comparison of the maximum
number of degenerate bases at any time point (as a per-
centage of the 399-bp gp41 ectodomain sequenced) and
the maximum pairwise distance (PD) between the
month 0 virus sequence and that of the most divergent
viral sequence was performed (Figure 1A, B). For the
acutely infected individuals this analysis revealed two
distinct groups of individuals (Figure 1A). A majority of
the individuals clustered in the low percentages (< 4%
maximum PD, < 3% maximum DB), while four exhibited
high percentages of both parameters (> 7% maximum
PD, > 6% maximum DB). One of these (ZM215F; arrow-
head) had been shown previously to be a case of co-
infection with two genetically distinct variants from a
single donor differing by a PD of more than 9% [42,43],
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while additional phylogenetic analyses (described below)
identified the remaining three individuals (black arrows)
as cases of superinfection (ZM282M, ZM211F, and
ZM247F).
A representative Highlighter plot http://www.hiv.lanl.
gov was compiled for each individual’s population
sequences and provided a visual representation of
homogeneity or heterogeneity of the viral population at
each time point relative to the virus population at the
time of the acutely infected partner’s seroconversion
(month 0) (Figure 1C-F). Nucleotide changes from the
month 0 sequence are demonstrated with tick marks
that bear colors unique to each nucleotide (A = green,
T = red, G = orange, C = light blue, Degenerate/ambig-
uous = dark blue; http://www.hiv.lanl.gov/content/
sequence/HIGHLIGHT/help.html).
This analysis showed that for a majority of the acutely
infected individuals (18/22), the gp41 sequence
remained relatively homogeneous with no evidence of
dual infection. An example of this is shown in Figure
1C for subject ZM289M, who exhibits only minimal
changes (1 base change at 3 months, 12 months, 24
months, and then 2 changes at 30 months) in the gp41
sequence of the infecting HIV-1 strain over 30 months.
Figure 1 Sequence and Highlighter Analysis of Longitudinal Samples Provides Evidence for Superinfection. Comparison of maximum
sequence divergence in gp41 versus the maximum number of degenerate bases at any time point within acutely infected individuals (A) and
chronically infected individuals (B). The maximum percentage of degenerate bases is plotted on the y-axis; the maximum percentage of genetic
distance is plotted along the x-axis. Black arrows indicate superinfected subjects; arrowhead indicates a subject co-infected with two variants
from a single donor. Highlighter plots for gp41 sequences of ZM289M (C), ZM282M (D), ZM247F (E), and ZM211 F (F) sampled at 0 to 36
months post-seroconversion (shown on right of plot). The sequence at each time point is compared to the initial infecting HIV-1 gp41 sequence.
Tick marks denote nucleotide changes from the seroconversion sequence (T = red, A = green, C = blue, G = yellow), with dark blue indicating
degenerate bases (See Methods).
Kraft et al. Retrovirology 2012, 9:22
http://www.retrovirology.com/content/9/1/22
Page 3 of 14
However, in the three individuals identified above evi-
dence of superinfection was obtained (Figure 1D-F). In
addition, for one individual, ZM215F, evidence for co-
infection by distinct variants from a single donor was
observed, confirming a previous study [43].
ZM282M (Figure 1D) has few base changes until 10
months, at which point there are 49 degenerate base
changes observed, consistent with a mixture of geneti-
cally distinct viruses at this time-point. Interestingly, the
Highlighter plot shows that the superinfecting virus pre-
sent at 10 months persists until 36 months when there
was evidence for emergence of a dominant recombinant
virus (see below). This superinfecting virus predomi-
nance is evident from the resolution of mixed bases
(blue ticks, representing mixed bases) to simple mis-
matched bases that are derived from the superinfecting
strain compared to the month 0 viral sequence.
Individual ZM247F (Figure 1E) was previously
reported to be co-infected by closely related variants
(PD 2.7%, corresponding to 11 nucleotide differences in
gp41) from the same individual at the time of acute
infection [43]. At month 3 post-infection there is evi-
dence of superinfection by a genetically distinct virus
(PD ~12%) that at this time point becomes the predomi-
nant strain, then at 18 months and 21 months, a signifi-
cant number of degenerate bases are observed (40 and
36, respectively) consistent with a re-emergence of the
initial virus strain that results in a mixture of it and the
superinfecting virus in the plasma. At 24 months, a
recombinant of the superinfecting strain again starts to
dominate.
ZM211F (Figure 1F) resembles ZM282M in that the
virus sequence is homogeneous until month 9 where
there is clear evidence for superinfection, with a mixture
in the viral population as seen by degenerate bases. By
month 18, the superinfecting virus sequence has become
dominant and remains the predominant strain until at
least 33 months.
Thus through a combination of degenerate base and
phylogenetic analyses on longitudinal sequenced sam-
ples, we identified three cases of superinfection in this
cohort. In order to rule out the possibility that we
might have missed cases of superinfection because of
rapid recombination between the superinfecting virus
and the initial infecting variant [44], we performed the
same analysis on a 400 bp segment of the gag gene
encoding a region of p24. The results of this analysis
(data not shown) did not reveal any additional cases of
superinfection.
Clinical characteristics of superinfected individuals
Table 1 shows the sexual behaviour data collected from
self-reported questionnaires for the 22 acutely infected
individuals abstracted from 2002-2010. The three
acutely infected individuals that were superinfected
(ZM282M, ZM247F, ZM211F) are compared against the
19 acutely infected individuals that were not superin-
fected. The comparison between groups was limited to
the first 12 months of primary infection during which
initial superinfection was observed. The ages were simi-
lar between the two groups. Genital infections or ulcers
were reported or visualized in all three participants in
the superinfected group, and in 36% of the not superin-
fected group, which was statistically significant (p =
0.01). Two individuals in each group had a positive RPR
titer in the first year of their HIV-1 infection (p = 0.02),
and there was no difference between Trichomonas infec-
tion within the couple between the groups (p = 0.31).
All individuals in the superinfected group had sexual
intercourse with at least one partner between each visit
(total of 12 visits over 1 year for 3 individuals). The
superinfected group reported 201 episodes of sexual
intercourse with condoms and 29 (12.6% of total) epi-
sodes of sexual intercourse without condoms (mean
values are shown in Table 1). Sex with a non-spousal
partner (11 episodes) was reported by one individual,
ZM282M, while both superinfected women denied
Table 1 Reported sexual activity of newly infected partner in 12 months post-primary infection
Variable Not Superinfected
(n = 19)
Superinfected
(n = 3)
p-value
Age 28 26 0.41
Female gender 47% 66% 0.43
Reported genital ulcer/infection 7/19 3/3 0.01
Sex with partner/no condom, mean (range)# 5.5 (0-26) 9.7 (2-24) 0.57
Sex with partner/with condom, mean (range)# 107.4 (10-322) 67 (11-112) 0.51
Sex/non-spousal partner (contacts; fraction reporting exposure) 5; (3/19) 11; (1/3)* 0.27
RPR positivity 2/19 2/3 0.02
Trichomonas (in female partner) 4/19 1/3 0.31
Pregnancy 1/9 0/2 0.70
* self report - rare for women
# mean value/yr in first year
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extra-marital contact. The non-superinfected group
reported 2042 episodes of sexual intercourse with con-
doms, and 104 episodes (4.8%) without condoms. Three
individuals in the not superinfected group reported hav-
ing extra-marital partners (ZM249M, ZM250M,
ZM184F). Only 1 of the newly infected women became
pregnant, although 4 of the cohabiting female partners
of the 13 acutely infected men became pregnant. All
men in this study were uncircumcised.
Analysis of incidence
The incidence of superinfection was determined over 12
month periods after seroconversion, and this was com-
pared against the calculated incidence of primary
Figure 2 Neighbor-joining tree of full-length SGA env sequences for ZM282M. Blue and red sequences represent the initial infection and
superinfection sequences, respectively, from the acutely infected subject ZM282M; black sequences are derived from the epidemiologically
unlinked cohabiting partner ZM282F, who is chronically infected. The time points are indicated along with M or F for each sequence (i.e. M_8 is
the acutely infected ZM282M at 8 months post seroconversion). The ZM282F “0” time point corresponds to seroconversion of ZM282M. The
duration of infection for ZM282F is not known. Bootstrap values > 80 are considered statistically significant. Sequences denoted by circles
indicate the parental sequences (blue, red circle) and those denoted by stars identify potential recombinant daughter sequences that were used
for recombination analyses (below).
Kraft et al. Retrovirology 2012, 9:22
http://www.retrovirology.com/content/9/1/22
Page 5 of 14
transmission within the larger cohort of enrolled sero-
discordant couples. The first 12 months showed 22 cou-
ples with an incidence of superinfection of 13.6 (5.2-
34.8, 95% CL) per 100 person years (py). During months
12-24 and 24-36, there were no further cases of superin-
fection in the remaining 19 patients.
All person-years of observation in the prospective
study were used to calculate overall HIV-1 incidence
rates in the broader cohort. Seroconversion and trans-
mission rates were calculated including all seroconver-
sions. Exact distribution methods were used to calculate
95% confidence intervals. In the first 3 months, the rate
was 13.1 (10.6-16.1, 95% CL), from 3-12 months after
enrollment, the rate was 7.9 (6.5-9.4, 95% CL), and the
rate between 12-24 and 24-36 months was 7.4 (5.9-9.0,
95% CL) and 7.2 (5.4-9.3, 95% CL), respectively. The
higher incidence of infection observed during the first 3
months following enrollment likely reflects infections
acquired immediately prior to couples counseling and
condom provision and that were still in the antibody
negative phase at the time of enrollment.
A comparison of incidence of superinfection in the
recent seroconvertors during the first year (13.6/100 py)
to the incidence of primary infection (per 100 person
years) in the broader discordant couple cohort during
either the 0-3 month (13.1) or 3-12 month (7.9) periods
using the t-test assuming equal variance yielded no sta-
tistically significant differences.
Characterization of superinfection by single genome
amplification
In order to better understand the dynamics of superin-
fection in the three individuals identified, single genome
amplification (SGA) of full-length env gene was per-
formed. The neighbor-joining (N-J) phylogenetic tree of
the sequences obtained for the male and female in cou-
ple ZM282 is shown in Figure 2. Sequences from the
chronically infected partner, subject ZM282F (black),
cluster distinctly from the male’s sequences (blue), con-
firming that these individuals are an unlinked transmis-
sion pair, and her sequences exhibit up to 3.5% diversity
(pairwise distance) consistent with that of a chronically
infected individual. For the male, the nearly identical
sequences from the earliest time point (M_0) branch
together, consistent with a genetic bottleneck in which a
single genetic variant was transmitted [42,45,46]. Lim-
ited genetic heterogeneity was observed over the next 8
months with the env sequences differing by only 1.1%
over this time. By contrast, at the M_10 time point, two
distinct virus populations were detected, with approxi-
mately 1/3 of the sequences forming a distinct,
Figure 3 Neighbor-joining tree representing full-length SGA
env sequences for ZM247F. Blue and red sequences represent the
env SGA sequences from acutely infected ZM247F (blue) and
superinfected (red) viral sequences. Black sequences are derived
from ZM247M, the epidemiologically unlinked chronically infected
partner. Bootstrap values > 80 are considered statistically significant.
Sequences denoted by circles indicate the parental sequences (blue,
red circle), and stars denote potential recombinant daughter
sequences (purple stars) that were used for recombination analyses
(below).
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genetically distant branch that is approximately 12.5%
divergent from the initial infecting virus (red). This is
consistent with the time of superinfection observed
from population sequence analysis of the gp41 encoding
region (Figure 1D). At subsequent times (12 and 18
month) there are sequences present that cluster with
the superinfecting virus and others that form another
distinct branch that represent recombinants (see below).
Only a minority of the sequences from the later time
points cluster with the initial infecting virus population,
consistent with the superinfecting virus becoming the
dominant viral population, as was also observed in gp41
Highlighter plot for this individual (Figure 1D).
Another example of almost complete dominance by
the superinfecting virus is seen with ZM247F. This indi-
vidual was initially infected by two variants that differ
by 2.7% from the same donor, evidenced by two distinct
branches of almost identical sequences [43] (Figure 3).
Consistent with the Highlighter analysis (Figure 1E), all
of the sequences amplified from the three-month time
point cluster independently from the initial infecting
viruses (red). These later sequences diverge over time
and include recombinants with the initial infecting virus
(see below), confirming the co-existence and genetic
interaction of both the initial and superinfecting virus
strains.
Figure 4 illustrates an example of what appears to be
superinfection of the chronically infected male partner
by his acutely infected spouse (ZM211M, Figure 4A),
and superinfection of the newly infected female partner
nine months later from an outside source (ZM211F, Fig-
ure 4B). In this case the chronically infected partner,
ZM211M (Figure 4A), has evidence of a distinct, diverse,
cluster of env variants, at the time of his partner’s sero-
conversion that represents the chronic viral population
(blue). However, in contrast to the chronically infected
partner in the other 2 cohabiting couples (ZM282 and
ZM247), there is evidence for superinfection in the male
at the time of his partner’s seroconversion, with a subset
of sequences that cluster closely with the woman’s acute
sequences (purple). Three months later, there is evi-
dence of recombinant variants developing that contain a
greater fraction of the man’s sequence (see below). We
interpret these findings to indicate that during acute
infection, the woman partner transmitted her genetically
distinct virus to her spouse, who died 6 months later.
Figure 4 Neighbor-joining tree of full length SGA env sequences for ZM211M and ZM211F. (A) The chronically infected ZM211M
sequences are depicted in blue, and the superinfecting ZM211F sequences are depicted in red, while those in purple represent potential
recombinant sequences between the blue and red sequences. (B) An expanded phylogenetic tree showing time points 0-36 months for the
acutely infected ZM211F initial infecting virus (blue) is distinct from ZM211M (black). Sequences denoted by circles indicate the parental
sequences (blue, red circle) and stars denote potential recombinant daughter sequences (purple stars) that were used for recombination
analyses described below.
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However, because plasma samples were not available
prior to the woman’s seroconversion time-point, it is
possible that the male was infected by two phylogeneti-
cally distinct viruses and that one of these is the source
of his spouse’s (ZM211F) primary infection. Recombina-
tion analyses described below are most consistent, how-
ever, with superinfection of the male by his acutely
infected partner.
ZM211F, the acutely infected partner, has a homoge-
nous viral population at her earliest time point, which
developed very limited diversity over the first 6 months
(Figures 1F, and 4B). At the 9-month time point,
ZM211F exhibits clear evidence of superinfection by a
virus (red) that is genetically distinct from her partner’s
(black).
In order to rule out evidence that superinfections
might have originated from contaminating sequences
within the cohort, we analyzed the env SGA sequences
from the three superinfection pairs in the context of
contemporaneous sequences from the cohort (Figure
5A). In each case a distinct superinfecting genetic var-
iant could be identified which segregated independently
on the phylogenetic tree. The extra-cohort origin of
these superinfecting strains was further supported by a
phylogenetic analysis of gp41 population sequences for
the viruses from all 22 couples (Figure 5B)
Recombination analysis using highlighter tool
One consequence of superinfection can be the genera-
tion of novel unique recombinant viruses, and evidence
for HIV-1 superinfection can be further supported in
the 3 couples analyzed here by evaluation of the
sequences for recombination. For each superinfected
individual, parental viruses were selected by generating a
consensus of full-length env SGA sequences from the
time of seroconversion and choosing a full-length env
SGA amplicon sequence that matched the consensus
sequence (filled blue circle). Similarly, parental superin-
fecting viruses were selected by comparing the chosen
viral env sequence against all env sequences at the time
of superinfection and selecting the superinfecting env
sequence with the greatest pairwise distance from the
seroconversion virus (filled red circle).
Figure 6A clearly shows that for each of the selected
ZM282M sequences recombinant variants have been
generated (purple stars, Figure 2). In the ZM282M_10
recombinant sequence for example, the C-terminal
region of gp120 and N-terminus of gp41 of the initially
Figure 5 Neighbor-joining trees of SGA env and population gp41 sequences for the cohort. (A) Neighbor-joining phylogenetic tree of
single genome amplified env gene sequences from each superinfected individual in the context of Zambian sub-type C env sequences. The
Zambian subtype C sequences include twelve of the non-superinfected, newly infected individuals from this study. Superinfected individuals are
assigned discrete colors and the superinfecting quasispecies is denoted by SI. (B) Neighbor-joining tree of gp41 sequences for all 22 couples.
Superinfected individuals are assigned discrete colors.
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infecting virus (blue) have been replaced by the superin-
fecting virus sequences (red). By contrast, as might be
predicted from its position on the N-J tree,
ZM282M_12 consists almost entirely of superinfecting
virus sequences, with only small regions of gp120 and
the C-terminus of gp41 originating in the initial acutely
infecting virus.
In the case of ZM247F (Figure 6B), however, despite
very distinct recombination patterns across the env gene
in the three cases chosen, a recombination break point
within the C-terminal domain of gp41 (residue 2200),
first observed at 12 months (F_12), was conserved in the
15 and 21 month sequences even though these variants
were located in distinct clusters on the N-J tree. This
suggests that this recombination event may have con-
ferred a specific fitness advantage.
In couple ZM211, we compared presumed recombi-
nant viruses in the chronically infected partner
ZM211M with virus sequences from both the ZM211M
quasi-species (blue circle, Figure 4A) and the ZM211F
initially infecting viruses (red circle, Figure 4A). In the
latter case (Figure 6C) the recombinant viruses cluster-
ing closely to the newly infecting ZM211F founder
sequence (purple stars, Figure 4A) exhibited discrete
recombination events, but also showed evidence of con-
served recombinant regions derived from ZM211M at
the very N-terminus of gp120.
Finally, a comparison of three putative recombinants
in the superinfecting population of ZM211F (purple
stars in Figure 4B) to the initial virus and the superin-
fecting strain at 9 months (ZM211F_9) revealed clear
evidence of recombination in the superinfecting strain
with acquisition of env sequences from the initially
infecting virus at the N-terminus of gp120 and the C-
terminal domain of gp41 being evident at 12 and 21
months. Thus in each of the four superinfected indivi-
duals, we observed extensive recombination with evi-
dence for co-existence of diverse recombinants at time
points subsequent to superinfection.
Discussion
Understanding the mechanism for HIV-1 superinfection
is crucial to the development of an HIV vaccine in
order to prevent HIV-1 acquisition in a naïve host, since
HIV-1 superinfection calls into question the idea that a
robust primary immune response to HIV-1 infection
provides some immunological protection from re-infec-
tion with a heterologous HIV-1. Superinfections occur-
ring in heterosexual cohabiting pairs have not been
studied in detail or longitudinally, despite the fact that
most primary infections occur in HIV-1 discordant cou-
ples [40,41]. Though discordant couples are considered
‘high risk,’ they are not typically thought to be exposed
to as many different viruses as sex workers or intrave-
nous drug users [31,47]. For this reason, it might be
predicted that superinfection would be observed at
lower frequency and would occur predominantly
between individuals within a couple; however, this was
not the case. In the 22 newly infected partners, who had
acquired HIV outside the marriage, we observed a fre-
quency of superinfection in these individuals in the first
year of follow up that was similar to that of primary
infection (13.6% vs. 7.8%, p > 0.05). Even though we
excluded couples in which the chronically infected part-
ners had viral loads lower than 1000 from this study, all
of the superinfections in the seroconverting partner ori-
ginated from a non-spousal partner. Thus, it is clear
that these couples are a higher risk subset of the cohort
with exposure to HIV-1 infection outside the main part-
nership. The very limited frequency of intra-couple
Figure 6 Highlighter recombination plots of full-length env for
each individual who was superinfected. Highlighter
recombination analysis of sequences from ZM282M (A), ZM247F (B),
and ZM211M (C) and ZM211F (D). The parental virus sequence from
the acutely infected or a representative parental sequence from the
chronically infected partner (ZM211M) are shown in blue in the first
bar of each panel. The superinfecting parental sequence shown in
red is the second bar. The presumptive recombinant daughter
sequences from three representative time points are shown below
the parents for each case of superinfection.
Kraft et al. Retrovirology 2012, 9:22
http://www.retrovirology.com/content/9/1/22
Page 9 of 14
superinfection (1/4) studied here in part reflects contin-
ued safe sexual practices within the couple, since greater
than 95% of reported sexual activity was with a condom.
Nevertheless, significant numbers of non-condom expo-
sures did occur (104/2146) in 19 of the 22 newly
infected partners who did not become superinfected.
Although self-report of external sexual activity is clearly
underreported [37], it seems unlikely that for each of
the three superinfected individuals, the number of
unprotected extra-marital exposures would exceed the
number within the marriage. Moreover, with an adult
seroprevalence rate of ~20% in Zambia, extramarital
exposures should in a majority of instances be with ser-
onegative individuals and therefore present less of a risk
of potential superinfection than with the known seropo-
sitive partner. Interestingly, a similar lack of intra-couple
superinfection has been observed in a recent study of 11
seroconcordant couples infected with disparate viruses
in Uganda [48].
One factor that could influence susceptibility to super-
infection is the presence of sexually transmitted diseases.
Since genital infections and ulcers break down mucosal
barriers and contribute to increased risk for primary
HIV infection [42,49,50]. In the analysis of behavioral
characteristics and clinical signs, the factors that trended
toward significance were the presence of GUD on physi-
cal exam and RPR positivity in the superinfected group
as compared to the non-superinfected group, although
7/19 non-superinfected individuals did have GUD. Pre-
vious studies in this Zambian cohort have shown a 2-3
fold increase in risk of HIV-1 infection in uninfected
partners with GUD, after correction for viral load in
their chronically infected partner [51-53]. In contrast to
this higher-risk group, longitudinal gag, pol, and nef
gene sequence data from 80 epidemiologically linked
transmission pairs in the cohort (where transmission
was from the cohabiting spousal partner) in the first
two years of follow-up have not demonstrated any evi-
dence of superinfection from non-spousal partners (data
not shown), consistent with a lower frequency of extra-
marital sexual activity in this cohort subset.
Despite the fact that a majority of the acutely infected
individuals in this study of ZEHRP transmission pairs
have > 2 years of follow-up, HIV-1 superinfection was
observed within the first year of follow-up in each of the
3 acutely superinfected individuals. This is consistent
with recent studies of intra-subtype superinfection in
subtype B infected individuals, where in one case mathe-
matical modeling indicated a 21-fold reduction of super-
infection after 1 year of infection [25], and in a second
case, a retrospective analysis of individuals in the San
Diego and Los Angeles Acute HIV Infection and Early
Disease Research Programs demonstrated 3 cases of
superinfection within 13 months of seroconversion [17].
In contrast, the timing of superinfection in a subtype A
commercial sex worker cohort appears less constrained,
with superinfection detected as late as 5 years after pri-
mary infection [26].
The analysis of longitudinal env sequences, amplified
by the SGA approach, for each of the individuals identi-
fied through degenerate base analysis allowed the defini-
tive resolution of both the timing and nature of
superinfection. In each of the three recent seroconver-
sion cases a distinct superinfecting genetic variant could
be identified which segregated independently on the
phylogenetic tree (Figure 5A). Recombination between
the primary infection variant and the superinfecting var-
iant was observed in each case; and at some time points,
consistent with the Highlighter analyses of population
sequences, these recombinants became the dominant
variant in the circulating virus population. Interestingly,
we observed the conservation of recombination break-
points within different variants in an individual over sev-
eral months, suggesting that recombinant viruses with
these particular sequence mixes possess fitness benefits
over either the initial or the superinfecting strain. This
is consistent with the observation of Streeck et al., [36],
who showed that recombination between initial and
superinfecting viruses could accelerate immunological
escape from cellular immune responses. In a more glo-
bal sense, the selection of mixed genotypes with
enhanced population fitness is evidenced by the numer-
ous circulating recombinant forms of HIV-1 resulting
from dual infection of individuals [9,33,34], which
clearly contribute to the overall diversity of a virus
population. Additional studies will be required to fully
characterize the basis of recombinant virus selection in
the subtype C infected individuals under study here.
The SGA analysis of viral sequences bolstered our
interpretation that ZM211M was superinfected from his
spousal partner, ZM211F, during her acute seroconver-
sion. At the time of her seroconversion, ZM211M has
two dominant and distinct quasispecies with limited evi-
dence for recombination between them. In contrast at
month 3, a distinct population of recombinant viruses
arises. This is consistent with superinfection of
ZM211M during his spouse’s acute viremia (viral load
greater than 750,000), followed by the emergence of
recombinants. Moreover, shortly after the probable
superinfection, the viral load of ZM211M increased 10-
fold and he is deceased within 6 months.
Determining why HIV-1 does or does not superinfect
an exposed individual will be crucial to understanding
the nature of an immune response that is capable of
preventing de novo infection. Given the considerable
antigenic dissimilarities between subtypes, we might not
expect that initial infection by one subtype of HIV-1
would provide significant immune protection against
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other subtypes; on the other hand we might expect
there to be some protection from reinfection of infected
patients by more closely related HIV-1 strains of the
same subtype. This does not appear to be the case dur-
ing the first year of infection in the subtype C infected
individuals studied here, where rates of intra-subtype
superinfection in the first year of study were similar to
those of primary infection [39]. However, it is of interest
that in the three individuals that are superinfected, little
variation in env sequences is observed in the period
prior to the superinfection event, suggesting that there
may be limited neutralizing antibody pressure on the
founder virus. Indeed, preliminary studies indicate the
absence of potent neutralizing antibody responses to the
founder virus at the visit prior to superinfection (D.
Basu et al., unpublished). It will be of interest to deter-
mine whether there is a more potent neutralizing anti-
body response in the non-superinfected individuals who
also report extra-marital contact. Moreover, given that
in this study each partner in the couple is infected with
a different strain of subtype C HIV-1, it is possible that
repeated exposure to a partner’s HIV-1 strain could sti-
mulate the development of HIV-1 specific immune
responses and that this might have provided protection
against intra-couple superinfection. This type of immune
stimulation with boosting of the cellular immune
response has been reported to occur in subtype B
infected men who have sex with men [23].
The existence of HIV-1 superinfection presents an
obstacle to develop a vaccine to prevent primary infec-
tion with HIV-1. With technologies such as next-gen-
eration sequencing being employed to detect HIV-1
superinfection [48], the detection of very small viral
sub-populations at a given time point will increase reso-
lution. There are behavioral and clinical aspects (e.g. cir-
cumcision, genital ulcers) that influence this
phenomenon but there are likely immunologic correlates
that render some individuals more susceptible to super-
infection. Continued study of HIV-1 superinfection
within cohabiting heterosexual couples can provide
insights into such correlates in the context of a poten-
tially highly susceptible and relatively low-risk cohort
type.
Methods
Zambian cohort
The Zambia Emory HIV Research Project (ZEHRP), a
Rwanda Zambia HIV Research Group (RZHRG) site in
Lusaka, Zambia, was established in order to study het-
erosexual cohabiting HIV-1 discordant couples, and pro-
vides voluntary testing and counseling as well as long-
term monitoring and health care to participating couples
[54,55]. HIV discordant couple is defined in this cohort
as a couple that upon screening and enrollment has one
HIV-infected partner (seropositive index partner) and
one HIV-uninfected partner [56]. This screening is
based on rapid HIV-1 antibody test positivity [54,57].
Both partners are followed quarterly with repeat coun-
seling and documentation of reported sexual exposures
within and outside the marriage, and assessment of bio-
logical markers of unprotected sex [37]. Plasma from
the seronegative partner is tested at every visit for HIV-
1 antibodies with rapid tests, and for the presence of
p24 antigen using the Vironostika® HIV-1 p24 antigen
ELISA [54,57]. Despite counseling and provision of con-
doms, and a two-thirds reduction in transmission [58],
approximately 7%-8% per year of the initially seronega-
tive partners are infected by HIV-1. Once a transmission
event had been established, the newly infected partner
was followed quarterly, and the chronically infected
partner at least annually. Blood products (PBMC and
plasma) were collected at each visit under protocols
approved by the University of Zambia Research Ethics
Committee and the Emory Institutional Review Board.
Plasma was obtained by centrifugation of whole blood,
and stored in aliquots at -80°C until use. Viral RNA was
extracted from these samples using the QIAamp® Viral
RNA Mini kit (Qiagen Inc., Valencia, CA). Individuals
who meet criteria for antiretroviral therapy are referred
elsewhere and drop out of the cohort studies.
Viral gp41 sequences from newly infected, previously
seronegative, individuals and their chronically infected
partners were used to define epidemiologic linkage of
the transmission as described by Trask et al., 2001 [41].
During the period 01/01/2002 to 06/01/2007, a total of
202 seroconversions were identified, of which 49 (24%)
were classified as unlinked. A total of 22 couples were
selected for further study based on the criteria: 1. Sam-
ples corresponding to at least one year of follow-up
were available at Emory University, and 2. The seroposi-
tive index partner had a viral load greater than 1000,
because we were interested in determining the fre-
quency of superinfection within the couple and primary
transmission from such individuals is rare. A table
detailing the available demographic, clinical and beha-
vioral characteristics of these individuals is provided in
Additional file 1: Table S1. Although the exact time of
transmission is not available, for each newly infected
partner, samples were collected within a median of 91
days (range 10-181 days) of the last seronegative visit.
For this study, we have defined two different types of
dual infection: co-infection is defined as the detection of
two genetically distinct viruses at the time of serocon-
version in the previously HIV-1 negative partner; super-
infection is defined as the detection of more than one
genetically distinct virus at least 3 months after primary
infection seroconversion in the seronegative partner. For
the seropositive index partner, superinfection was
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defined as the detection of a novel genetically distinct
variant at or after the time of infection of their serone-
gative partner.
HIV-1 gp41 and gag nested PCR
Viral RNA was reverse-transcribed using SuperScript® III
One-Step RT-PCR System with Platinum® Taq High Fide-
lity as per manufacturer’s guidelines (Invitrogen Co.,
Carlsbad, CA). Nested PCR amplifications using Expand
High Fidelity polymerase (Roche Applied Science, Indiana-
polis, IN) were performed for gp41 as previously described
and in Additional file 2: Methods [41]. Purified positive
amplicons were sent out for direct sequencing to MWG
Sequencing (Huntsville, AL). Nested PCR for gag was
accomplished using the following primers: Outer: 5’ -
TTC TAC GGA GAC TCC ATG ACC C - 3’, 5’ - ATT
TGA CTA GCG GAG GCT AGA A - 3’, Inner: 5’ - ATT
GCT TCA GCC AAA ACT CTT GC - 3’, 5’ - CGA CCA
AAA TTA CCC TAT AGT GCA G - 3’, and sequencing
primers: 5’ - GGG ACA TCA AGC AGC CAT- 3’, 5’ -
GCC AAA GAG TGA TTT GAG GG - 3’.
Sequence analysis and highlighter analysis
Sequences were analyzed from amplicons in Sequencher
4.8 (Gene Codes Corporation, Ann Arbor, MI). Gen-
eious Pro (Biomatters Ltd, Auckland, New Zealand)
software was used to align sequences, and neighbor-
joining trees were generated using the Tamura-Nei
genetic distance model with the bootstrap resampling
method. Additionally, the Highlighter tool from Los Ala-
mos National Laboratory HIV Sequence Database http://
www.hiv.lanl.gov/content/sequence/HIGHLIGHT/high-
lighter_top.html was used to map mutations deviating
from the earliest sample. APOBEC G to A mutations
(open diamonds) and degenerate bases (Dark Blue) were
quantified in a longitudinal fashion within the acute
transmission partner’s virus with respect to the viral
sequence from the time of seroconversion. Recombina-
tion analysis was performed using the Highlighter tool
for analysis of the presumed parent and daughter
sequences.
Env single genome analysis (SGA)
Single genome PCR amplification was performed of the
entire env gene [42,43]. Single genome analysis was con-
ducted on couples who were determined to have dual
infection by the screening methods of degenerate base
counting, HMA or phylogenetic analysis of sequences
encoding gp41. Full-length env gene sequences were
analyzed for superinfection cases (ZM211M, ZM211F,
ZM282M, ZM247F).
Degenerate base counting
After obtaining the sequences from gp41 PCR ampli-
cons, degenerate or ambiguous codes were manually
counted using the International Union of Pure and
Applied Chemistry (IUPAC) designations. Only nucleo-
tide positions where the secondary (and occasionally ter-
tiary) peak was at least 30% as high as the primary peak
was counted as a mixed peak, and these had to be pre-
sent in both forward and reverse primer sequences.
Degenerate codes were then assigned to the mixed
nucleotide accordingly.
Heteroduplex mobility assay
Second round gp41 PCR products amplified from
plasma were used directly in the heteroduplex assay as
described elsewhere [8,59].
HIV-1 quantitative viral loads
HIV-1 viral load determination was performed on
plasma using the Amplicor HIV-1 Monitor Test, v 1.5
(Roche Diagnostics, Indianapolis IN).
Statistical analysis of behavioral data
A univariate analysis to compare the superinfected and
non-superinfected groups was performed using the Wil-
coxon rank sum test, or Fisher’s exact test as appropriate,
for continuous variables. Categorical variables were com-
pared using the chi-square statistic. All analyses were per-
formed using SAS® version 9.2 (Cary, NC), and p-values <
0.05 were considered to be statistically significant. The
95% confidence interval for incidence of infection was cal-
culated based on the method by Clopper and Pearson [60].
Additional material
Additional file 1: Table S1.
Additional file 2: Methods. Nested PCR reagents and cycling
conditions.
Acknowledgements
We would like to acknowledge the staff and volunteers of the Zambia
Emory HIV Research Project. We would like to thank Dr. Jesse T. Jacob, and
Amanda Tichacek for assistance with the behavioral statistics.
Financial support: The work was supported by grants from the National
Institutes of Health (AI-51231; MH-66767; HD-40951) and the International
AIDS Vaccine Initiative. The Virology Core of the Emory Center for AIDS
Research (P30 AI050409) provided support for viral load testing. NIH AI-
0678501 supported PTH. An NRSA Institutional Postdoctoral Training Grant
T32 AI-007470 through the Emory Microbiology and Molecular Genetics
Program and National Institutes of Health/National Center for Research
Resources KL2 RR-025009 supported CSK. The Fogarty AITRP grant (D43
TW001042) sponsored WK. Funding institutions played no role in the
conduct of these studies or in the preparation, review or approval of the
manuscript.
Kraft et al. Retrovirology 2012, 9:22
http://www.retrovirology.com/content/9/1/22
Page 12 of 14
Nucleotide sequences: GenBank SGA accession numbers for ZM247:
EU166779-EU166856
GenBank population sequencing for gp41: GU827726-GU827976
Author details
1Emory Vaccine Center at Yerkes National Primate Research Center, Emory
University, Atlanta, GA, USA. 2Los Alamos National Laboratory, Los Alamos,
NM, USA. 3Zambia Emory HIV Research Project, ZEHRP, Lusaka, Zambia.
4Department of Global Health, Rollins School of Public Health, Emory
University, Atlanta, GA, USA. 5Projet San Francisco, Rwanda Zambia HIV
Research Group, RZHRG, Kigali, Rwanda.
Authors’ contributions
CSK and DB performed the experiments, analyzed the data and drafted the
manuscript. PAH performed the experiments on ZM211F. PTH did the
analysis of the pairwise distance for all individuals. EC, JM, and WK are vitally
involved in the sample collection in the discordant couple cohort and
critically reviewed the manuscript. CD participated in the design of the
experiments and critically reviewed the manuscript. OM utilized the HMA for
screening for superinfection, directed the sample collection and critically
reviewed the manuscript. NHK performed statistical analyses. EH conceived
of the study, participated in its design and coordination and critically
reviewed the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 December 2011 Accepted: 20 March 2012
Published: 20 March 2012
References
1. Chohan BH, Piantadosi A, Overbaugh J: HIV-1 Superinfection and its
Implications for Vaccine Design. Curr HIV Res 2010, 8:596-601.
2. Allen TM, Altfeld M: HIV-1 superinfection. J Allergy Clin Immunol 2003,
112:829-835.
3. van der Kuyl AC, Cornelissen M: Identifying HIV-1 dual infections.
Retrovirology 2007, 4:67.
4. Jost S, Bernard MC, Kaiser L, Yerly S, Hirschel B, Samri A, Autran B, Goh LE,
Perrin L: A patient with HIV-1 superinfection. N Engl J Med 2002,
347:731-736.
5. Chohan B, Lavreys L, Rainwater SM, Overbaugh J: Evidence for frequent
reinfection with human immunodeficiency virus type 1 of a different
subtype. J Virol 2005, 79:10701-10708.
6. Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Kaslow RA, Shepherd JC,
Margolick JB, Mullins JI: HIV type 1 superinfection with a dual-tropic virus
and rapid progression to AIDS: a case report. Clin Infect Dis 2007,
45:501-509.
7. Hu DJ, Subbarao S, Vanichseni S, Mock PA, Ramos A, Nguyen L,
Chaowanachan T, Griensven F, Choopanya K, Mastro TD, Tappero JW:
Frequency of HIV-1 dual subtype infections, including intersubtype
superinfections, among injection drug users in Bangkok, Thailand. AIDS
2005, 19:303-308.
8. Manigart O, Courgnaud V, Sanou O, Valea D, Nagot N, Meda N, Delaporte E,
Peeters M, Van de Perre P: HIV-1 superinfections in a cohort of
commercial sex workers in Burkina Faso as assessed by an autologous
heteroduplex mobility procedure. AIDS 2004, 18:1645-1651.
9. McCutchan FE, Hoelscher M, Tovanabutra S, Piyasirisilp S, Sanders-Buell E,
Ramos G, Jagodzinski L, Polonis V, Maboko L, Mmbando D, et al: In-depth
analysis of a heterosexually acquired human immunodeficiency virus
type 1 superinfection: evolution, temporal fluctuation, and
intercompartment dynamics from the seronegative window period
through 30 months postinfection. J Virol 2005, 79:11693-11704.
10. Ramos A, Hu DJ, Nguyen L, Phan KO, Vanichseni S, Promadej N,
Choopanya K, Callahan M, Young NL, McNicholl J, et al: Intersubtype
human immunodeficiency virus type 1 superinfection following
seroconversion to primary infection in two injection drug users. J Virol
2002, 76:7444-7452.
11. van der Kuyl AC, Kozaczynska K, van den Burg R, Zorgdrager F, Back N,
Jurriaans S, Berkhout B, Reiss P, Cornelissen M: Triple HIV-1 infection. N
Engl J Med 2005, 352:2557-2559.
12. Yerly S, Jost S, Monnat M, Telenti A, Cavassini M, Chave JP, Kaiser L,
Burgisser P, Perrin L: HIV-1 co/super-infection in intravenous drug users.
AIDS 2004, 18:1413-1421.
13. Plantier JC, Lemee V, Dorval I, Gueudin M, Braun J, Hutin P, Ruffault A,
Simon F: HIV-1 group M superinfection in an HIV-1 group O-infected
patient. AIDS 2004, 18:2444-2446.
14. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT,
Montefiori DC, O’Connor DH, Davis BT, Lee PK, et al: HIV-1 superinfection
despite broad CD8+ T-cell responses containing replication of the
primary virus. Nature 2002, 420:434-439.
15. Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Grobler J, Li F, Liu SL,
Rademeyer C, Learn GH, Karim SS, et al: Dual HIV-1 infection associated
with rapid disease progression. Lancet 2004, 363:619-622.
16. Koelsch KK, Smith DM, Little SJ, Ignacio CC, Macaranas TR, Brown AJ,
Petropoulos CJ, Richman DD, Wong JK: Clade B HIV-1 superinfection with
wild-type virus after primary infection with drug-resistant clade B virus.
AIDS 2003, 17:F11-F16.
17. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES,
Richman DD, Little SJ: Incidence of HIV superinfection following primary
infection. Jama 2004, 292:1177-1178.
18. Chakraborty B, Valer L, De Mendoza C, Soriano V, Quinones-Mateu ME:
Failure to detect human immunodeficiency virus type 1 superinfection
in 28 HIV-seroconcordant individuals with high risk of reexposure to the
virus. AIDS Res Hum Retroviruses 2004, 20:1026-1031.
19. Gonzales MJ, Delwart E, Rhee SY, Tsui R, Zolopa AR, Taylor J, Shafer RW:
Lack of detectable human immunodeficiency virus type 1 superinfection
during 1072 person-years of observation. J Infect Dis 2003, 188:397-405.
20. Tsui R, Herring BL, Barbour JD, Grant RM, Bacchetti P, Kral A, Edlin BR,
Delwart EL: Human immunodeficiency virus type 1 superinfection was
not detected following 215 years of injection drug user exposure. J Virol
2004, 78:94-103.
21. Rachinger A, Manyenga P, Burger JA, de Ven TLPDV, Stolte IG, Prins M, van’t
Wout AB, Schuitemaker H: Low incidence of HIV-1 superinfection even
after episodes of unsafe sexual behavior of homosexual Men in the
Amsterdam cohort studies on HIV infection and AIDS. J Infect Dis 2011,
203:1621-1628.
22. Rachinger A, van de Ven TD, Burger JA, Schuitemaker H, Schuitemaker H,
van’t Wout AB: Evaluation of pre-screening methods for the
identification of HIV-1 superinfection. J Virol Methods 2010, 165:311-317.
23. Willberg CB, McConnell JJ, Eriksson EM, Bragg LA, York VA, Liegler TJ,
Hecht FM, Grant RM, Nixon DF: Immunity to HIV-1 is influenced by
continued natural exposure to exogenous virus. PLoS Pathog 2008, 4:
e1000185.
24. Blish CA, Dogan OC, Derby NR, Nguyen MA, Chohan B, Richardson BA,
Overbaugh J: Human immunodeficiency virus type 1 superinfection
occurs despite relatively robust neutralizing antibody responses. J Virol
2008, 82:12094-12103.
25. Bragg L, McConnell J, Liegler T, Bacchetti P, Spotts G, Hecht F, Grant R: HIV-
1 suoerinfection surveillence in an acute infection cohort using pol
sequences from resistance genotyping: 1996-200. California: In
Conference on Retoviruses and Opportunistic Infections; San Francisco;
2010.
26. Piantadosi A, Chohan B, Chohan V, McClelland RS, Overbaugh J: Chronic
HIV-1 infection frequently fails to protect against superinfection. PLoS
Pathog 2007, 3:e177.
27. Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y,
Petropolous CJ, Daar ES, Little SJ, Richman DD: Lack of neutralizing
antibody response to HIV-1 predisposes to superinfection. Virology 2006,
355:1-5.
28. Blick G, Kagan RM, Coakley E, Petropoulos C, Maroldo L, Greiger-
Zanlungo P, Gretz S, Garton T: The probable source of both the primary
multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid
progression to AIDS and a second recombinant MDR strain found in a
chronically HIV-1-infected patient. J Infect Dis 2007, 195:1250-1259.
29. Chakraborty B, Kiser P, Rangel HR, Weber J, Mirza M, Marotta ML, Asaad R,
Rodriguez B, Valdez H, Lederman MM, Quinones-Mateu ME: Can HIV-1
superinfection compromise antiretroviral therapy? AIDS 2004, 18:132-134.
30. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ,
Richman DD, Little SJ: HIV drug resistance acquired through
superinfection. AIDS 2005, 19:1251-1256.
Kraft et al. Retrovirology 2012, 9:22
http://www.retrovirology.com/content/9/1/22
Page 13 of 14
31. Grobler J, Gray CM, Rademeyer C, Seoighe C, Ramjee G, Karim SA, Morris L,
Williamson C: Incidence of HIV-1 dual infection and its association with
increased viral load set point in a cohort of HIV-1 subtype C-infected
female sex workers. J Infect Dis 2004, 190:1355-1359.
32. Sagar M, Lavreys L, Baeten JM, Richardson BA, Mandaliya K, Chohan BH,
Kreiss JK, Overbaugh J: Infection with multiple human immunodeficiency
virus type 1 variants is associated with faster disease progression. J Virol
2003, 77:12921-12926.
33. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM: The challenge of
HIV-1 subtype diversity. N Engl J Med 2008, 358:1590-1602.
34. Gross KL, Porco TC, Grant RM: HIV-1 superinfection and viral diversity.
AIDS 2004, 18:1513-1520.
35. Taylor JE, Korber BT: HIV-1 intra-subtype superinfection rates: estimates
using a structured coalescent with recombination. Infect Genet Evol 2005,
5:85-95.
36. Streeck H, Li B, Poon AFY, Schneidewind A, Gladden AD, Power KA,
Daskalakis D, Bazner S, Zuniga R, Brander C, et al: Immune-driven
recombination and loss of control after HIV superinfection. J Exp Med
2008, 205:1789-1796.
37. Allen S, Meinzen-Derr J, Kautzman M, Zulu I, Trask S, Fideli U, Musonda R,
Kasolo F, Gao F, Haworth A: Sexual behavior of HIV discordant couples
after HIV counseling and testing. AIDS 2003, 17:733-740.
38. Allen S, Serufilira A, Bogaerts J, Van de Perre P, Nsengumuremyi F, Lindan C,
Carael M, Wolf W, Coates T, Hulley S: Confidential HIV testing and
condom promotion in Africa. Impact on HIV and gonorrhea rates. JAMA
1992, 268:3338-3343.
39. Fideli US, Allen SA, Musonda R, Trask S, Hahn BH, Weiss H, Mulenga J,
Kasolo F, Vermund SH, Aldrovandi GM: Virologic and immunologic
determinants of heterosexual transmission of human immunodeficiency
virus type 1 in Africa. AIDS Res Hum Retroviruses 2001, 17:901-910.
40. Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C,
Greenberg L, Allen S: New heterosexually transmitted HIV infections in
married or cohabiting couples in urban Zambia and Rwanda: an analysis
of survey and clinical data. Lancet 2008, 371:2183-2191.
41. Trask SA, Derdeyn CA, Fideli U, Chen Y, Meleth S, Kasolo F, Musonda R,
Hunter E, Gao F, Allen S, Hahn BH: Molecular epidemiology of human
immunodeficiency virus type 1 transmission in a heterosexual cohort of
discordant couples in Zambia. J Virol 2002, 76:397-405.
42. Haaland RE, Hawkins PA, Salazar-Gonzalez J, Johnson A, Tichacek A, Karita E,
Manigart O, Mulenga J, Keele BF, Shaw GM, et al: Inflammatory genital
infections mitigate a severe genetic bottleneck in heterosexual
transmission of subtype A and C HIV-1. PLoS Pathog 2009, 5:e1000274.
43. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF,
Derdeyn CA, Farmer P, Hunter E, Allen S, et al: Deciphering human
immunodeficiency virus type 1 transmission and early envelope
diversification by single-genome amplification and sequencing. J Virol
2008, 82:3952-3970.
44. Piantadosi A, Ngayo MO, Chohan B, Overbaugh J: Examination of a second
region of the HIV type 1 genome reveals additional cases of
superinfection. AIDS Res Hum Retroviruses 2008, 24:1221.
45. Derdeyn CA, Decker JM, Bibollet-Ruche F, Mokili JL, Muldoon M,
Denham SA, Heil ML, Kasolo F, Musonda R, Hahn BH, et al: Envelope-
constrained neutralization-sensitive HIV-1 after heterosexual
transmission. Science 2004, 303:2019-2022.
46. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG,
Sun C, Grayson T, Wang S, Li H, et al: Identification and characterization of
transmitted and early founder virus envelopes in primary HIV-1
infection. Proc Natl Acad Sci USA 2008, 105:7552-7557.
47. Blish CA, Blay WM, Haigwood NL, Overbaugh J: Transmission of HIV-1 in
the face of neutralizing antibodies. Curr HIV Res 2007, 5:578-587.
48. Redd AD, Collinson-Streng A, Martens C, Ricklefs S, Mullis CE, Manucci J,
Tobian AAR, Selig EJ, Laeyendecker O, Sewankambo N, et al: Identification
of HIV superinfection in seroconcordant couples in Rakai, Uganda, by
Use of next-generation deep sequencing. J Clin Microbiol 2011,
49:2859-2867.
49. Roest RW, Maertzdorf J, Kant M, van der Meijden WI, Osterhaus ADME,
Verjans GMGM: High incidence of genotypic variance between sequential
herpes simplex virus type 2 isolates from HIV-1-seropositive patients
with recurrent genital herpes. J Infect Dis 2006, 194:1115-1118.
50. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O,
Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, et al: Rates of HIV-1
transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
J Infect Dis 2005, 191:1403-1409.
51. Merino A, Malhotra R, Morton M, Mulenga J, Allen S, Hunter E, Tang J,
Kaslow RA: Impact of a functional KIR2DS4 allele on heterosexual HIV-1
transmission among discordant Zambian couples. J Infect Dis 2011,
203:487-495.
52. Song W, He D, Brill I, Malhotra R, Mulenga J, Allen S, Hunter E, Tang J,
Kaslow RA: Disparate associations of HLA class I markers with HIV-1
acquisition and control of viremia in an African population. PLoS One
2011, 6:e23469.
53. Tang J, Shao W, Yoo YJ, Brill I, Mulenga J, Allen S, Hunter E, Kaslow RA:
Human leukocyte antigen class I genotypes in relation to heterosexual
HIV type 1 transmission within discordant couples. J Immunol 2008,
181:2626-2635.
54. McKenna SL, Muyinda GK, Roth D, Mwali M, Ng’andu N, Myrick A, Luo C,
Priddy FH, Hall VM, von Lieven AA, et al: Rapid HIV testing and counseling
for voluntary testing centers in Africa. AIDS 1997, 11(Suppl 1):S103-S110.
55. Allen S, Karita E, Chomba E, Roth DL, Telfair J, Zulu I, Clark L, Kancheya N,
Conkling M, Stephenson R, et al: Promotion of couples’ voluntary
counselling and testing for HIV through influential networks in two
African capital cities. BMC Publ Health 2007, 7:349.
56. Kempf MC, Allen S, Zulu I, Kancheya N, Stephenson R, Brill I, Tichacek A,
Haworth A, Chomba E: Enrollment and retention of HIV discordant
couples in Lusaka, Zambia. J Acquir Immune Defic Syndr 2008, 47:116-125.
57. Boeras DI, Luisi N, Karita E, McKinney S, Sharkey T, Keeling M, Chomba E,
Kraft C, Wall K, Bizimana J, et al: Indeterminate and discrepant rapid HIV
test results in couples’ HIV testing and counselling centres in Africa. J Int
AIDS Soc 2011, 14:18.
58. Allen SA, Chomba E, Karita E, Kilembe W, Inambao M, Streeb G: The
contribution of HIV-discordant relationships to new HIV infections: a
rebuttal. AIDS 2011, 25:1341-1343.
59. Delwart EL, Sheppard HW, Walker BD, Goudsmit J, Mullins JI: Human
immunodeficiency virus type 1 evolution in vivo tracked by DNA
heteroduplex mobility assays. J Virol 1994, 68:6672-6683.
60. Clopper C, Pearson ES: The use of confidence or fiducial limits illustrated
in the case of the binomial. Biometrika 1943, 26:403-413.
doi:10.1186/1742-4690-9-22
Cite this article as: Kraft et al.: Timing and source of subtype-C HIV-1
superinfection in the newly infected partner of Zambian couples with
disparate viruses. Retrovirology 2012 9:22.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kraft et al. Retrovirology 2012, 9:22
http://www.retrovirology.com/content/9/1/22
Page 14 of 14
